229 related articles for article (PubMed ID: 27306689)
21. Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis.
Chaudhary R; Singh A; Chaudhary R; Bashline M; Houghton DE; Rabinstein A; Adamski J; Arndt R; Ou NN; Rudis MI; Brown CS; Wieruszewski ED; Wanek M; Brinkman NJ; Linderbaum JA; Sorenson MA; Atkinson JL; Thompson KM; Aiyer AN; McBane RD
JAMA Netw Open; 2022 Nov; 5(11):e2240145. PubMed ID: 36331504
[TBL] [Abstract][Full Text] [Related]
22. Venous thrombosis in patients with high-grade glioma.
Taillibert S; Taillandier L; Le Rhun E
Curr Opin Oncol; 2015 Nov; 27(6):516-21. PubMed ID: 26447877
[TBL] [Abstract][Full Text] [Related]
23. Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.
Donato J; Campigotto F; Uhlmann EJ; Coletti E; Neuberg D; Weber GM; Zwicker JI
Blood; 2015 Jul; 126(4):494-9. PubMed ID: 25987658
[TBL] [Abstract][Full Text] [Related]
24. Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors.
Miller EJ; Patell R; Uhlmann EJ; Ren S; Southard H; Elavalakanar P; Weber GM; Neuberg D; Zwicker JI
Blood Adv; 2022 Mar; 6(5):1559-1565. PubMed ID: 35086145
[TBL] [Abstract][Full Text] [Related]
25. Safety of long-term anticoagulation in patients with brain metastases.
Horstman H; Gruhl J; Smith L; Ganti AK; Shonka NA
Med Oncol; 2018 Mar; 35(4):43. PubMed ID: 29497873
[TBL] [Abstract][Full Text] [Related]
26. Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents.
Perry JR
Curr Opin Neurol; 2010 Dec; 23(6):592-6. PubMed ID: 20881488
[TBL] [Abstract][Full Text] [Related]
27. Balancing bleeding in brain metastases.
Kreuziger LB
Blood; 2015 Jul; 126(4):432-3. PubMed ID: 26206944
[TBL] [Abstract][Full Text] [Related]
28. Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases.
Leader A; Hamulyák EN; Carney BJ; Avrahami M; Knip JJ; Rozenblatt S; Beenen LFM; Yust-Katz S; Icht O; Coppens M; Raanani P; Middeldorp S; Büller HR; Zwicker JI; Spectre G
Blood Adv; 2020 Dec; 4(24):6291-6297. PubMed ID: 33351124
[TBL] [Abstract][Full Text] [Related]
29. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
Franco L; Giustozzi M; Agnelli G; Becattini C
J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
[TBL] [Abstract][Full Text] [Related]
30. Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma.
Dasgupta P; Rousseau JF
J Neurooncol; 2024 Feb; 166(3):569-574. PubMed ID: 38286976
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the yield of 24-h close observation in patients with mild traumatic brain injury on anticoagulation therapy: a retrospective multicenter study and meta-analysis.
Verschoof MA; Zuurbier CCM; de Beer F; Coutinho JM; Eggink EA; van Geel BM
J Neurol; 2018 Feb; 265(2):315-321. PubMed ID: 29236167
[TBL] [Abstract][Full Text] [Related]
32. Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
Becattini C; Cimini LA; Carrier M
Thromb Res; 2021 Apr; 200():41-47. PubMed ID: 33529872
[TBL] [Abstract][Full Text] [Related]
33. Bevacizumab and risk of intracranial hemorrhage in patients with brain metastases: a meta-analysis.
Yang L; Chen CJ; Guo XL; Wu XC; Lv BJ; Wang HL; Guo Z; Zhao XY
J Neurooncol; 2018 Mar; 137(1):49-56. PubMed ID: 29170906
[TBL] [Abstract][Full Text] [Related]
34. Nationwide patterns of hemorrhagic stroke among patients hospitalized with brain metastases: influence of primary cancer diagnosis and anticoagulation.
Lee V; Jairam V; Yu JB; Park HS
Sci Rep; 2020 Jun; 10(1):10084. PubMed ID: 32572113
[TBL] [Abstract][Full Text] [Related]
35. Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review.
Gorman J; Candeloro M; Schulman S
Thromb Haemost; 2023 Oct; 123(10):966-975. PubMed ID: 37015326
[TBL] [Abstract][Full Text] [Related]
36. Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism.
Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
Res Pract Thromb Haemost; 2020 Jul; 4(5):860-865. PubMed ID: 32685895
[TBL] [Abstract][Full Text] [Related]
37. Effect of oral anticoagulation therapy in atrial fibrillation patients with a history of intracranial hemorrhage: a systematic review and meta-analysis.
Liu M; Hou Y; Liu W; Liu M
Ann Palliat Med; 2022 Oct; 11(10):3063-3074. PubMed ID: 35948473
[TBL] [Abstract][Full Text] [Related]
38. Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies.
Swartz AW; Drappatz J
Oncologist; 2021 May; 26(5):427-432. PubMed ID: 33523555
[TBL] [Abstract][Full Text] [Related]
39. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study.
Reed-Guy L; Desai AS; Phillips RE; Croteau D; Albright K; O'Neill M; Brem S; O'Rourke DM; Amankulor NM; Bagley SJ
Neuro Oncol; 2022 Dec; 24(12):2172-2179. PubMed ID: 35551405
[TBL] [Abstract][Full Text] [Related]
40. Vascular complications in patients with brain tumors.
Diaz M; Schiff D
Curr Opin Oncol; 2022 Nov; 34(6):698-704. PubMed ID: 35788556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
